Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

Reaction Rate

Reaction Rate

The rate of reaction is the change in the amount of a reactant or product per unit time. Reaction rates are therefore determined by measuring the time dependence of some property that can be related to reactant or product amounts. Rates of reactions that consume or produce gaseous substances, for example, are conveniently determined by measuring changes in volume or pressure.
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...

Voltaic/Galvanic Cells

Voltaic/Galvanic Cells

Spontaneous Chemical Reactions
Spontaneous redox reactions occur abundantly in nature. The chemical reaction occurring in a disposable AA battery powering our remote controls is one such example of a spontaneous redox reaction. Another example is the immersion of coiled copper wire into an aqueous silver nitrate solution. The reaction shows a gradual, visually impressive color change from colorless to bright blue and the formation of a grey precipitate on the copper wire. In this experiment,...

Measuring Reaction Rates

Measuring Reaction Rates

Polarimetry finds application in chemical kinetics to measure the concentration and reaction kinetics of optically active substances during a chemical reaction. Optically active substances have the capability of rotating the plane of polarization of linearly polarized light passing through them—a feature called optical rotation. Optical activity is attributed to the molecular structure of substances. Normal monochromatic light is unpolarized and possesses oscillations of the electrical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

Ophthalmology·2026

Same author

Combination of color-Doppler ultrasound and MRI to improve lacrimal gland lesion characterization: A machine learning approach.

Diagnostic and interventional imaging·2026

Same author

Intereye differences in myopic macular degeneration, intraocular pressure and axial length: the Two-Continent Eye Study.

The British journal of ophthalmology·2026

Same author

Radiological management of reversible cerebral vasoconstriction syndrome (RCVS) in France: a national multicenter survey.

AJNR. American journal of neuroradiology·2026

Same author

Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir.

Annals of clinical and translational neurology·2026

Same author

Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria.

Journal of neuroradiology = Journal de neuroradiologie·2026

Search research articles

Related Experiment Video

Updated: Feb 1, 2026

Multifocal Electroretinograms

Multifocal Electroretinograms

Published on: December 4, 2011

[Progressive multifocal leukoencephalopathy].

Antoine Moulignier¹, Augustin Lecler², Cédric Lamirel³

¹Service de neurologie.

La Revue Du Praticien

|December 5, 2018

Summary

This summary is machine-generated.

Progressive multifocal leukoencephalopathy (PML) is a fatal CNS disease caused by JC virus reactivation during immunosuppression. Current treatment focuses on restoring immune response, as no specific effective therapy exists.

Keywords:

Encéphalopathie

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Related Experiment Videos

Last Updated: Feb 1, 2026

Multifocal Electroretinograms

Multifocal Electroretinograms

Published on: December 4, 2011

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Area of Science:

Neurology
Virology
Immunology

Background:

Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system (CNS).
It is caused by the human polyomavirus JC (JCV), which establishes a latent infection.
Reactivation of JCV, often due to immunosuppression, leads to PML and other CNS complications.

Purpose of the Study:

To provide a comprehensive overview of Progressive Multifocal Leukoencephalopathy (PML).
To discuss the role of JC virus (JCV) and immunosuppression in PML pathogenesis.
To outline diagnostic approaches and current therapeutic strategies for PML.

Main Methods:

Review of existing literature on PML.
Analysis of JCV reactivation mechanisms under immunosuppressive conditions.
Summary of diagnostic criteria including MRI, CSF analysis, and neuropathology.
Evaluation of treatment strategies aimed at immune reconstitution.

Main Results:

PML is a lethal CNS disease resulting from JC virus reactivation.
Immunosuppression, including HIV, monoclonal antibody therapy, and transplantation, is a critical factor.
Clinical manifestations vary based on lesion location.
Diagnosis relies on neuroimaging, JCV detection in cerebrospinal fluid, and potentially brain biopsy.

Conclusions:

PML is a devastating opportunistic infection of the CNS.
Effective treatments are lacking, emphasizing the importance of managing underlying immunosuppression.
Restoring the host immune response is the primary therapeutic goal for PML.